This report contains market size and forecasts of Kidney Cancer Targeted Therapy in Global, including the following market information: Global Kidney Cancer Targeted Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions) Global top five companies in 2021 (%) The global Kidney Cancer Targeted Therapy market was valued at US$ million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028. The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028. Tyrosine Kinase Inhibitors Segment to Reach $ Million by 2028, with a % CAGR in next six years. The global key manufacturers of Kidney Cancer Targeted Therapy include Merck, Novartis, Pfizer, Roche, Amgen, Aveo Pharmaceuticals, Exelixis, Bayer and Eisai, etc. In 2021, the global top five players have a share approximately % in terms of revenue. MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Kidney Cancer Targeted Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks. Total Market by Segment: Global Kidney Cancer Targeted Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions) Global Kidney Cancer Targeted Therapy Market Segment Percentages, by Type, 2021 (%) Tyrosine Kinase Inhibitors mTOR Inhibitors EGFR Inhibitors Anti-VEGF Monoclonal Antibody Global Kidney Cancer Targeted Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions) Global Kidney Cancer Targeted Therapy Market Segment Percentages, by Application, 2021 (%) Renal Cell Cancer Renal Pelvis Cancer Others Global Kidney Cancer Targeted Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) Global Kidney Cancer Targeted Therapy Market Segment Percentages, By Region and Country, 2021 (%) North America US Canada Mexico Europe Germany France U.K. Italy Russia Nordic Countries Benelux Rest of Europe Asia China Japan South Korea Southeast Asia India Rest of Asia South America Brazil Argentina Rest of South America Middle East & Africa Turkey Israel Saudi Arabia UAE Rest of Middle East & Africa Competitor Analysis The report also provides analysis of leading market participants including: Key companies Kidney Cancer Targeted Therapy revenues in global market, 2017-2022 (estimated), ($ millions) Key companies Kidney Cancer Targeted Therapy revenues share in global market, 2021 (%) Further, the report presents profiles of competitors in the market, key players include: Merck Novartis Pfizer Roche Amgen Aveo Pharmaceuticals Exelixis Bayer Eisai Wyeth
1 Introduction to Research & Analysis Reports 1.1 Kidney Cancer Targeted Therapy Market Definition 1.2 Market Segments 1.2.1 Market by Type 1.2.2 Market by Application 1.3 Global Kidney Cancer Targeted Therapy Market Overview 1.4 Features & Benefits of This Report 1.5 Methodology & Sources of Information 1.5.1 Research Methodology 1.5.2 Research
